SOW
LXRX icon

State of Wyoming’s Lexicon Pharmaceuticals LXRX Stock Holding History

State of Wyoming’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8K Sell
10,779
-49,792
-82% -$72.4K ﹤0.01% 1690
2025
Q4 		$69.7K Buy
60,571
+52,045
+610% +$71.5K 0.01% 1434
2025
Q3 		$11.5K Buy
+8,526
New +$9.68K ﹤0.01% 1753

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State of Wyoming's LXRX Position: Q1 2026 in Review

State of Wyoming reduced its Lexicon Pharmaceuticals (LXRX) stake by 82% in Q1 2026, selling an estimated $72.4K and leaving 10,779 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

State of Wyoming first reported a position in LXRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $69.7K in Q4 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • State of Wyoming held 10,779 shares of Lexicon Pharmaceuticals worth $16.8K as of Q1 2026.
  • State of Wyoming sold 49,792 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $72.4K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1690 holding.
  • State of Wyoming first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • State of Wyoming's Lexicon Pharmaceuticals position peaked at $69.7K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.